Mouse and human T cell Cas9-RNP/nucleofection-mediated gene-editing
Authors:
- 16 April 2025
- book chapter
- Published by Elsevier
- Vol. 201, 91-107
Abstract
No abstract availableKeywords
Funding Information
- Lymphoma Research Foundation (N/A)
- Cancer Research Institute (3445)
- Bristol-Myers Squibb (#CA209\u2013976)
This publication has 32 references indexed in Scilit:
- Improving homology-directed repair efficiency in human stem cellsMethods, 2019
- Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9Protein & Cell, 2017
- DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated BreaksMolecular Cell, 2016
- Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9Nature, 2016
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas SystemCell, 2015
- Rapid and highly efficient mammalian cell engineering via Cas9 protein transfectionJournal of Biotechnology, 2015
- Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9Cell Stem Cell, 2014
- In Vitro Enzymology of Cas92014
- Comparison of nonhomologous end joining and homologous recombination in human cellsDNA Repair, 2008
- siRNA stabilization prolongs gene knockdown in primary T lymphocytesEuropean Journal of Immunology, 2008